100 employees
MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.
2007
$30M
from 2 investors over 2 rounds
MSI Methylation Sciences Inc. raised $30M on October 6, 2016
Investors: Quark Venture
MSI Methylation Sciences Inc. raised $18M on September 29, 2011
Investors: Inventages Venture Capital